Best Life Sciences Platforms and Tools Companies in Capital Region of Denmark, Denmark
The 57 best Life Sciences Platforms and Tools companies in Capital Region of Denmark, Denmark in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Upfront Chromatography.
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Platforms and Tools companies in Capital Region of Denmark
| # | Company | Disclosed funding | Last round | Employees | Founder | Stage | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Upfront Chromatography Provides chromatography technology for protein separation processes | $32M | 221 mo ago | 5 | — | Series B | 118 patents Large‑scale chromatography media and processes for protein and oligosaccharide purification | — |
| 2 | BioImage Developer of bioassays for biopharmaceutical companies and research institutions | $30M | 293 mo ago | 42 | Fuhui Long Co-Founder | Acqui-Hired | 9 patents Patents concentrated in chemistry & materials | — |
| 3 | Biosyntia Developing biocatalysts using synthetic biology and metabolic engineering technology | $23M | 48 mo ago | 19 19 → 22 (+16%) | Hans Genee Co-Founder and CSO | Series B | — | — |
| 4 | Exiqon Develops LNA-based tools for diagnostics and research | $23M | 127 mo ago | 65 | — | Acquired | 187 patents MicroRNA-based diagnostics and quantification for prostate cancer detection and prognosis | — |
| 5 | Rivelin Drug delivery platform to deliver a pharmaceutical drug uni-directional to a mucosal surface | $20M | 110 mo ago | 6 | — | Series A | — | — |
| 6 | Immudex Provider of immune monitoring reagents and services for research and clinical use | $19M | 17 mo ago | 39 39 → 46 (+18%) | Patrik Dahlen Chief Executive Officer | Series A | — | — |
| 7 | Flow Robotics Provider of an AI-based laboratory automation robot system for liquid handling | $17M | 49 mo ago | 28 | Andres Faina Co-Founder | Series A | 6 patents Automated laboratory tube handling and scanning robotics for high-throughput testing. | — |
| 8 | Borean Pharma Protein technology platform for the development of human protein products | $17M | 254 mo ago | — | Johanna Holldack Ex - CEO | Series A | 10 patents Engineered protein biologics: cytokine/TNF antagonists, HIV fusion inhibitors, protease‑cleavable therapeutics | — |
| 9 | Samplix ApS Provider of microfluidics-based technology for the encapsulation of microbial and mammalian cells | $13M | 39 mo ago | 26 26 → 31 (+19%) | Marie Mikkelsen Co-founder & CTO | Series A | 65 patents Fluorinated surfactant microfluidics for droplet generation, sorting, and DNA enrichment | — |
| 10 | Nuevolution Developer of drug treatments for oncology and chronic inflammatory diseases | $12M | 168 mo ago | 40 | — | Acquired | 335 patents Design of heterocyclic small‑molecule modulators for nuclear receptors and bromodomain targets | — |
| 11 | Clinical Microbiomics Provider of meta-genomics platform and services | $10M | 45 mo ago | 26 | — | Series A | — | 1 job opening · 1 partnership |
| 12 | Inniti Developer of an IoT device for laboratory management | $4M | 62 mo ago | 6 | Anders Rasmussen Co-Founder | Series A | — | — |
| 13 | GlycoSpot Provider of solutions for high throughput enzyme screening | $4M | 49 mo ago | 7 | Mads Hartvig Clausen Founder | Seed | — | 1 partnership |
| 14 | Twelve Bio Developer of CRISPER technology based diagnostics and therapeutics | $3M | 69 mo ago | 10 | Stefano Stella Co-Founder & CEO | Acquired | — | — |
| 15 | PixieGene Provider of a genetically modified porcine models for research for degenerative aging disorders | $2M | 112 mo ago | — | Kaj Vestergaard CEO | Deadpooled | — | — |
| 16 | Immunitrack Provider of a broad portfolio of reagents and immunogenicity assays | $1M | 68 mo ago | 12 | Sune Justesen Co-Founder | Seed | — | — |
| 17 | Fidabio Provider of tech-enabled protein and nano-particle analysis services | $1M | 67 mo ago | 17 17 → 39 (+129%) | — | Seed | — | 1 launch |
| 18 | Anapa Biotech Molecular tools to enhance the nucleic acids in PCR-based assays | $1M | 233 mo ago | 1 | Soren Echwald Owner & CEO | Series A | 7 patents Dual-quencher multiplex fluorescence assays for sensitive nucleic acid detection | — |
| 19 | Biomatics Technology Developer of an instrument system for automated sampling and real-time monitoring | $961K | 72 mo ago | 1 | Jesper Bryde-Jacobsen Managing Director | Seed | — | — |
| 20 | Fluisense Provider of a blood sampling and storage device | $333K | 66 mo ago | 8 | Malene Schroder Co-Founder & CEO | Seed | — | — |
| 21 | OptoRobotix Develoeper of flow cytometers for cell sorting | $328K | 130 mo ago | 2 | — | Funding Raised | — | — |
| 22 | COBO Technologies Manufacturer of products for genome editing | $270K | 86 mo ago | 2 | Jens Ole Bock Co-Founder & CEO | Seed | — | — |
| 23 | atSpiro Developer of an automated single-use bioreactor for fermentation and cell cultivation of microbial cells | $173K | 66 mo ago | 4 | Toke Faurby Co-Founder & CEO | Seed | — | — |
Top 12 Life Sciences Platforms and Tools companies in Capital Region of Denmark
#1
Series A · Copenhagen, Capital Region of Denmark · founded 2009 · 39 employees$19Mraised▾
Provider of immune monitoring reagents and services for research and clinical use. It offers a portfolio of products, including dextramer reagents for flow cytometry and other applications, Klickmer reagents, and custom solutions. The products are used to detect and characterize antigen specific immune cells, supporting research in areas such as vaccine development, cell therapy, and infectious disease. It also provides services such as custom allele production and proficiency testing. Its offerings enable researchers and clinicians to gain a deeper understanding of the immune response in various contexts.It provides a range of products and services such as Dextramer and dcode MHC multimers for detailed immune profiling, clinical grade reagents, monomers and U- Load reagents, techincal and scientfic support, and more.
- Feb 2025Series A$290.6K
- Feb 2024Series A$305.1K
- Mar 2023Series A$245.5K
- Apr 2022Series A$249K
#2
Series A · Birkerod, Capital Region of Denmark · founded 2013 · 26 employees$12.8Mraised▾
Provider of microfluidics-based technology for the encapsulation of microbial and mammalian cells. The company has developed a microfluidics instrument called Xdrop that encapsulates the target living cells, DNA fragments, or organelles together with the assay chemistry is highly stable double-emulsion droplets. It has applications for cell reaction screening and verification of gene edits.
- Mar 2023Grant (prize money)—
- Apr 2021Grant (prize money)$60.6K
- Dec 2020Series A$6.6M
- May 2019Grant (prize money)$2.1M
#3
Series B · Copenhagen, Capital Region of Denmark · founded 2012 · 19 employees$23.4Mraised▾
Biosyntia uses synthetic biology and metabolic engineering to produce biocatalysts with its patent-pending high-throughput screening technology. Their biocatalysis process enables complex chemical production by fermentation and also reduce both production costs and environmental impact as compared to another chemical synthesis.
- Jul 2022Series B$15.5M
- Apr 2018Series A$4.9M
- Jan 2018Grant (prize money)$348.4K
- Jan 2017Grant (prize money)$584.5K
#4
Series A · Copenhagen, Capital Region of Denmark · founded 2015 · 28 employees$17.1Mraised▾
Provider of an AI-based laboratory automation robot system for liquid handling. It enables users to assist, automate, handle, analyze, process, manage, and control laboratory activities. Its product portfolio includes liquid handling robots, scanners, plates, shakers, and accessories. Its offering includes lab automation tools, research tools, and material handling tools.
- May 2022Series A$12.6M
- May 2021Seed$2.5M
- Aug 2020Seed$56.9K
- Jun 2019Seed$814.6K
#5
Series A · Horsholm, Capital Region of Denmark · founded 2016 · 26 employees$9.7Mraised▾
Provider of meta-genomics platform and services. The company offers a comprehensive portfolio of services for microbiome studies such as Kits supply, Sample storage, metagenomics, transcriptomics, specialized microbiome characterization (e.g. real-time qPCR and strain type analysis), bioinformatics, and statistical analysis. It also provides customized sequencing solutions based on a particular project.
- Oct 2022Series A$9.7M
- Jan 2021Grant (prize money)$364.9K
- Sep 2020Grant (prize money)$354.7K
- Sep 2018Grant (prize money)$345.7K
#6
Acquired · Vedbaek, Capital Region of Denmark · founded 1995 · 65 employees$22.9Mraised▾
Exiqon develops LNA-based (Locked Nucleic Acid) tools for diagnostics and research. It has two major business units: Life Science and Diagnostics. Exiqon Life Sciences develops LNA-based kits for research use. Exiqon Diagnostics uses LNA-based tools for biomarker detection and the development of novel molecular diagnostic tests. In April 2016, Qiagen acquired Exiqon for $103M.
- Nov 2015Conventional Debt$40M
- Jun 2005Series B$19.7M
- Dec 2003Series A$3.2M
#7
Series B · Copenhagen, Capital Region of Denmark · founded 1992 · 5 employees$32.3Mraised▾
Upfront Chromatography is a biotech company that develops and manufactures products and technologies for extraction and recovery of biotherapeutics, functional biomolecules, macromolecular complexes, and even living cells. The company offers its patented technology Rhobust EBA process for high density chromatography adsorbent beads, among others.
#8
Acqui-Hired · Copenhagen, Capital Region of Denmark · founded 1999 · 42 employees$30.5Mraised▾
Developer of technologies to visualize the real-time movements and interactions of proteins in living cells. The company discovers pharmaceutical compounds and drug targets through the use of cell-based imaging technologies that track redistribution events in intracellular signaling pathways.
#9
Seed · Frederiksberg, Capital Region of Denmark · founded 2014 · 7 employees$3.6Mraised▾
Provider of services for glycoscience and screening of carbohydrate-modifying enzymes, helping to create better and more sustainable food & beverage products. The company provides services for glycoscience and offers rapid screening of carbohydrate-modifying enzymes by reducing the technology gap, enabling breweries, malthouses, dairies, and other food producers to focus on raising sustainability, and save time, and lowering their costs at the same time.
#10
Series A · Copenhagen, Capital Region of Denmark · founded 2014 · 6 employees$20.2Mraised▾
Drug delivery platform to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company is providing a bio-adhesive and bio-degradable patch, with a long adhesion time and high flexibility, conforming to the mucosal surface. Rivelin Plain Patch which is used as a mechanical barrier occluding mucosal ulcers and inflammation (Phase 1); Rivelin Clobetasol Patch is developed for Oral Lichen Planus (OLP).
- Apr 2017Series A$17.7M
- Sep 2015Seed$2.5M
#11
Series A · Aarhus, Capital Region of Denmark · founded 2001$16.8Mraised▾
Borean Pharma is focussed on developing human protein products using its proprietary technology. It three patented proprietary technologies include C-type lectin-related protein library that provides antibody mimics; trimerized tetranectin module which is a carrier for proteins, protein fragments and peptides for target ligands and protein refolding technology which enables large scale of antibody mimics in E. coli culture. It claims that its protein products will be the successors of the antibody based technology that currently constitutes the basis for the majority of the pharmaceutical protein products presently under clinical development.
- Apr 2005Series A$7.1M
- Dec 2001Series A$9.7M
#12
Series A · Copenhagen, Capital Region of Denmark · founded 2017 · 6 employees$3.8Mraised▾
Developer of an IoT device for laboratory management. The company has developed a device that assists with data analysis and automation. It has features for data collection, automation management, cloud-based management, monitoring, and analysis.
- May 2021Series A$3.3M
- Apr 2021Seed$182.1K
- Jun 2019Seed$308.9K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics is moving in Denmark
A read on the academic research around Bioinformatics — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 593 Denmark-affiliated papers.
- University of Copenhagen183
- Aarhus University121
- Technical University of Denmark118
- Novo Nordisk Foundation65
- Copenhagen University Hospital59
- Gene2→25
- Genome5→19
- DNA sequencing2→10
- Population1→8
- Metagenomics2→8
- Gene2→8
- Metagenomics1→5
- Microbiome1→5
- DNA sequencing2→5
- microRNA1→4
- Gene2→5
Where bioinformatics is researched across Denmark
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.